Background and Aims: The original Geboes Score [OGS] is the most commonly used histological score in ulcerative colitis [UC], but rather complicated to use in daily clinical practice. The aim of this study was to develop a Simplified Geboes Score [SGS] and to compare it with the OGS in patients newly diagnosed with UC. Methods: All patients diagnosed with UC at a tertiary referral centre between 2005 and 2010, who had serial colonoscopies with biopsies, were retrospectively included. The 5-year endoscopic/ histological evolution after diagnosis was recorded. Histological activity was scored by an experienced inflammatory bowel disease pathologist and three trained readers using the OGS and also the new SGS that only includes variables linked to active inflammatory disease. The correlation between endoscopic and histological activity and the histological inter-observer agreement were measured. Results: A total of 528 slides from 339 colonoscopies of 103 UC patients were reviewed. Forty . The correlation analysis between endoscopy and OGS/SGS did not show significant differences between the histological scores. The inter-observer agreement was moderate for all the grades of the SGS. Conclusions: The assessments of histological activity based on the OGS and the SGS were comparable in newly diagnosed active UC patients. Further prospective validation should now be done to replace the OGS with the SGS.
Introduction
The introduction of powerful biologic drugs such as anti-tumour necrosis factor [TNF] and anti-leucocyte trafficking agents for the treatment of ulcerative colitis [UC] has pushed the endpoints of medical management towards mucosal healing. However, endoscopy is not a good predictor of histological healing, and the presence of histological activity in patients with both clinical and endoscopic quiescent UC has been associated with a higher risk of relapse or development of cancer. [1] [2] [3] [4] Therefore histological evaluation remains important after diagnosis of UC.
Numerous histological scores have been proposed for UC but none have been validated. Nevertheless, the Geboes Score [see Table 1 ] has been the most used in clinical trials. The complexity of the score, however, limits its applicability in clinical practice. 5 It is divided in 6 grades: architectural changes [ The aim of the current study was to develop a Simplified Geboes Score [SGS] [see Table 2 and Figure 1 ] and to compare its performance with the original Geboes Score [OGS] by correlating both scores with endoscopic activity in patients recently diagnosed with UC.
Materials and Methods

Design
All consecutive adult patients who were newly diagnosed with UC between 2005 and 2010 and had serial endoscopies with biopsies performed at the Endoscopy Department of the University Hospitals Leuven [Belgium] , were retrospectively included. The 5-year histological evolution after diagnosis was recorded.
All patients had a minimum of one or several [range [2] [3] [4] [5] [6] colonoscopies over the study period. During the colonoscopy, biopsies were put in tubes containing a predefined volume of Carnoy's solution or 4% neutral buffered formalin. Biopsies in a single tube were representative either of the complete colon or of a segment of the colon [biopsies from inflamed areas in the cases of active disease, or standard biopsies from the rectosigmoid in cases where no active disease was observed endoscopically]. For every tube received in the pathology laboratory, a paraffin block was made and a corresponding 5-µm haematoxylin-eosin stained slide was prepared according to routine diagnostic procedures.
Demographic data [gender, age] and UC characteristics (age at diagnosis, UC extent based on Montreal classification, smoking habit, inflammatory bowel disease [IBD] family history and biomarkers) were recorded at inclusion. Endoscopic activity was based on the Mayo Endoscopic Subscore. 6 Histological inflammatory activity was scored by an experienced gastrointestinal pathologist [GDH] and three trained readers [AJ, AG, YD], using the original OGS [ Table 1 ] and the SGS [ Table 2 ]. 5 The three trained readers had no previous experience in gastrointestinal [GI] histopathology before the study; these readers were trained in UC histopathology by two experienced gastrointestinal pathologists [GDH and KG] . The training set consisted of 200 slides from non-related UC endoscopy procedures. Cases were reviewed and scored by the trainees, and thoroughly discussed with the experts using a multi-headed microscope. The slides of the present study were read by at least two observers, i.e. the expert and one trained reader, both of whom were blinded to the endoscopic results.
The primary objective of the study was to develop the SGS and to compare it with the OGS with regard to the accuracy of the microscopic descriptions of the endoscopic findings in patients newly diagnosed with UC and followed up over 5 years. A secondary objective included inter-observer agreement.
Simplified Geboes Score
A simplified histological score based on the previous OGS was developed [see Figure 1 ]. 5 The SGS describes histological features which are called grades. In contrast to the OGS, there are now 5 such grades. Variables linked to active inflammation were taken from the OGS: neutrophils in the lamina propria, neutrophils in the epithelium, and epithelial injury in the crypts and at the mucosal surface, because neutrophils are highly increased in number in active UC. Eosinophils in lamina propria were also included because, although they can be present in both active and quiescent disease, the severity of eosinophil infiltration in lamina propria has been associated with UC relapse and non-response to medical therapy. 7, 8 In addition, basal plasmacytosis was included as a scoring variable, as it has been previously identified as a predictor of relapse. 2, 9 Grade 0 of the SGS comprises grades 0 and 1 of the OGS and has been included in the SGS to allow scoring of biopsies which show no active inflammation but where signs of previous disease are still present. This refers to both architectural changes [e.g. branching crypts, crypt atrophy or loss] and the presence of an increased mononuclear cell infiltrate.
We limited grade 1 to a single component of the chronic inflammatory infiltrate, namely basal plasmacytosis [BP] , as it seems to be the stronger predictor for clinical relapse. 2, 9, 10 BP is defined as the presence of plasma cells around or below the crypts [deep fifth of the lamina propria], alongside or penetrating the muscularis mucosae. Grade 2, eosinophils and neutrophils in lamina propria, was maintained as in the previous score but divided into only 3 subgrades The presence of epithelial injury in association with neutrophils is also a marker of increased disease activity. Epithelial injury in the OGS was separated into 2 independent grades: grade 4 represented damage to crypt epithelium and grade 5 represented damage to surface epithelium. It should be mentioned that this score was created in the context of a trial of budesonide, so the investigators estimated that a division of epithelial damage into crypt and surface injury was needed to test the effects of oral and topical treatment on histology. 5 In the new classification, grade 4 comprised both grades 4 and 5 of the OGS, as they represent epithelial injury at crypts and on the surface, and was subdivided in 5 subgrades: 4 The findings were summarized for each endoscopy by selecting as the final score the highest obtained subgrade in the slide showing the most disease activity. The presence of neutrophils in the epithelium is required for the histological diagnosis of active disease. For the purpose of the study, we defined histologically active disease as a total score ≥ 3.1 in both histological scores.
Correlation between the histological scores and the Mayo Endoscopic Subscore
A validated endoscopic score was chosen in order to perform the correlation of both histological scores [OGS and SGS] Among the existing endoscopic scores for UC, the Mayo Endoscopic Subscore is used in routine clinical practice at our centre. 6 In order to make correlations between the Mayo Endoscopic Subscore and both histological scores, it was necessary to create conversions of the histological scores. The OGS is divided into 6 grades, the SGS into 5 and the Mayo Endoscopic Subscore into 4. Therefore, both histological scores were converted to a 4-tiered grading system to allow us to do comparisons with the endoscopic score; grade 0 was created for defining normal bowel tissue or inactive colitis, grade 1 corresponded to mild disease, grade 2 to moderate disease and grade 3 to severe disease. Many conversions are possible, depending on which subgrades are combined.
Two different conversions from the OGS were constructed based on the results of a previous study. 11 In this study, by Lemmens et al., nine different conversions were tested, using various upper and lower limits of grades 2 and 3. Biopsies without neutrophils were scored as grade 0. If neutrophils were present, the biopsies were categorized as at least grade 1. When ulcerations were found, biopsies were scored as grade 3. Between these extremes, the classification depended on the density and localization of neutrophils and the degree of epithelial damage. Conversions 3 and 9 showed the best results in this previous study, so they have been applied in the present one. 
Inter-observer agreement
Evaluation of basal plasmacytosis as a histological parameter
The association between active microscopic disease and the presence of BP was assessed. 
Statistical analysis
Categorical variables were described in proportions and continuous variables as mean (standard deviation [SD] ). Categorical data were compared using a chi-square test. Correlation between endoscopic and histological findings was analysed by the Kendall rank correlation coefficient, a non-parametric test that measures the strength of dependence between two categorical variables. The kappa coefficient was used to measure inter-observer agreement for qualitative items when codes are ordered. It ranges from 0 to 1: a perfect agreement would equate to a kappa of 1, excellent agreement 0.81-0.99, good agreement 0.61-0.80, moderate agreement 0.41-0.60, low agreement 0.21-0.40 and very low agreement < 0.20. 12 Statistical analysis was performed using the statistical package SPSS 18 for Windows [SPSS Inc., Chicago, IL].
Results
Patients
We 
Correlation between endoscopy and the histology scores
The comparison of the endoscopic and histological scores is presented in Figure 2 
Inter-observer agreement
The results of the scoring of all separate grades in the OGS and the SGS made by any of the three trained readers were compared with those obtained by the experienced gastrointestinal pathologist using kappa coefficients. 
Discussion
To date, 20 different histological scoring systems for UC have been published, but only two of them have been recently validated, the Nancy Score and the Robarts Histopathology Index. [13] [14] [15] The Nancy score comprises three histological items that define five grades of histological activity: absence of significant histological disease, chronic inflammatory infiltrate with no acute inflammatory infiltrate, mildly active disease, moderately active disease and severely active disease. 14 The Robarts histopathology index, includes four grades: chronic inflammatory infiltrate, lamina propria neutrophils, neutrophils in the epithelium and erosions or ulcerations. 15 Although they are simpler to use than the OGS, they do not include the presence of basal plasmacytosis or eosinophils in lamina propria. 15 The absence of eosinophils in these scores is acceptable because the function of these cells in IBD remains incompletely understood. The exclusion of basal plasmacytosis is less clear. Most probably this item is included in the 'chronic inflammatory infiltrate'. This is however defined in the Robarts study as 'round cells in the lamina propria' and in the Nancy index as the quantity of lymphocytes and plasma cells in the biopsy specimen. These definitions do not take into account the basal location of these cells as it occurs in UC nor the importance of the distribution pattern for both diagnosis and relation with disease activity. In our opinion, the absence of these two parameters limits the value of the scores because both, especially basal plasmacytosis, have been identified in multiple studies as predictors of UC evolution as relapse or non-response to medication .2,7-9 We therefore developed a simplified histological score for UC, the SGS, derived from the OGS. The new score comprised those variables associated with inflammatory activity and/or prediction of relapse. The number of subcategories in the SGS was also reduced compared with the OGS and as stated above, we added basal plasmacytosis. 2, 9 Neutrophils and epithelial damage were kept in the SGS as markers of microscopic activity of UC. Eosinophils in lamina propria were also included, because they are clearly increased in active disease and have also been associated with relapse or lack of response to medication in previous studies, although they may also be active in quiescent disease. 7, 8 In a first step, we assessed the correlation of both histological scores [OGS and SGS] with a validated endoscopic score, the Mayo Endoscopic Subscore. An endoscopic score is considered more reliable than clinical symptoms or biomarkers in the assessment of activity in UC. 6 Among the existing endoscopic scores for UC, the Mayo Endoscopic Subscore is used in routine clinical practice in our centre. The correlations of both histological scores with the endoscopic score were comparable in this cohort of newly diagnosed UC patients.
Next, we investigated the inter-observer agreement between an experienced gastrointestinal pathologist and the trained readers. Overall, a moderate agreement was reached for both the different grades and the final score of the SGS, being in this last case higher for SGS [kappa 0.56] than for the original GS [0.4]. The detection of histological activity reached a good agreement [kappa 0.7] for the SGS. We consider these as good results, especially when keeping in mind that recently trained readers were involved, and that these agreement coefficients do not differ from those obtained in other studies. 5, 16 We therefore think that this simplified score could be easily taught to pathologists or gastroenterologists without a large experience in reading IBD biopsies, thereby possibly facilitating the development of clinical trials in IBD that comprise histological assessment.
As in previous studies, microscopic active disease based on the presence of neutrophils in the epithelium or epithelial injury was observed in a significant proportion of patients in endoscopic remission. Histological grade ≥ 3.1 was detected in 25% of patients with complete endoscopic remission [Mayo Endoscopic Subscore 0] but increased to 84% when mild endoscopic disease [Mayo Endoscopic Subscore 1] was identified. We feel it is important that randomized trials in UC with novel compounds also take into account histology in order to study the ability of new drugs to induce histological healing. This is important, as persistent histological activity has been associated with higher relapse rates.
The inclusion of BP in the SGS [grade 1], defined as the presence of plasma cells in the deepest part of the lamina propria or below the crypts, alongside or penetrating the muscularis mucosae, represents the main change between the original and the proposed score. In previous studies, BP has been associated with a higher risk of relapse in UC patients in endoscopic remission. 2, 9 In the present study, the presence of BP was also significantly associated with a higher degree of endoscopic activity and the presence of microscopically active disease.
The main limitation of this study is its retrospective nature. In adddition, as the role of the eosinophils in lamina propria [grade 2A in both scores] could not be evaluated, the importance of eosinophils in the evolution of the UC or their relation with IBD medications is still not clear and will have to be determined in further studies.
Further validation of the SGS will be necessary in a prospective trial. We believe that a validated SGS has the potential to be implemented in clinical trials and routine practice to assess histological healing in UC. Prospective trials will provide evidence if histological healing beyond mucosal healing favourably impacts on the evolution of the disease.
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